umu.sePublikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Psoriasis therapy in real life: the need for registries
Umeå universitet, Medicinska fakulteten, Institutionen för folkhälsa och klinisk medicin, Dermatologi och venereologi.ORCID-id: 0000-0002-3858-8474
2006 (Engelska)Ingår i: Dermatology, ISSN 1018-8665, E-ISSN 1421-9832, Vol. 213, nr 4, s. 327-330Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

The introduction of new therapeutic options for the management of psoriasis is a challenge for the dermatology community, and new tools are needed to face this challenge. This article argues for the establishment of profession-based registries to collect solid, long-term data on the safety and effectiveness of different psoriasis treatment regimens. Managed by health care professionals, registries will be most successful if they enroll patients based on indications for treatment rather than on drugs given. This protects the evaluation process from commercial influences and allows a fair comparison of old- versus new-generation psoriasis treatments. In contrast to the patients in a registry who receive care in the natural clinical setting, subjects in randomized clinical trials (RCTs) are selected according to study criteria and may therefore not reflect the experience of patients in clinical practice. It is possible that particular risks and opportunities in the real patient population may therefore go undetected in RCTs.

Copyright © 2006 S. Karger AG, Basel

Ort, förlag, år, upplaga, sidor
S. Karger, 2006. Vol. 213, nr 4, s. 327-330
Nyckelord [en]
Adverse Drug Reaction Reporting Systems, Clinical Medicine, Dermatologic Agents/adverse effects/contraindications/*therapeutic use, Humans, Longitudinal Studies, Psoriasis/*drug therapy, Quality Assurance; Health Care, Randomized Controlled Trials as Topic, Registries, Risk Assessment, Safety, Treatment Outcome
Nationell ämneskategori
Dermatologi och venereologi
Identifikatorer
URN: urn:nbn:se:umu:diva-6843DOI: 10.1159/000096196ISI: 000242372000010PubMedID: 17135739OAI: oai:DiVA.org:umu-6843DiVA, id: diva2:146513
Tillgänglig från: 2007-12-18 Skapad: 2007-12-18 Senast uppdaterad: 2018-06-09Bibliografiskt granskad

Open Access i DiVA

Fulltext saknas i DiVA

Övriga länkar

Förlagets fulltextPubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=17135739&dopt=Citation

Personposter BETA

Schmitt-Egenolf, Marcus

Sök vidare i DiVA

Av författaren/redaktören
Schmitt-Egenolf, Marcus
Av organisationen
Dermatologi och venereologi
I samma tidskrift
Dermatology
Dermatologi och venereologi

Sök vidare utanför DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 134 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf